Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM) - Attal, M; Richardson, P G; Rajkumar, S V (Lancet, 2019)
. doi:10.1016/S0140-6736(19)32556-5